Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : OTO-6XX
Therapeutic Area : Otolaryngology (Ear, Nose, Throat)
Study Phase : Preclinical
Sponsor : Otonomy
Deal Size : Undisclosed
Deal Type : Licensing Agreement
Details : Otonomy, entered exclusive license agreement with KYORIN Pharmaceutical that provides Otonomy with exclusive worldwide rights to develop, manufacture and commercialize a novel compound for the treatment of sensorineural hearing loss.
Product Name : OTO-6XX
Product Type : Other Small Molecule
Upfront Cash : Undisclosed
March 08, 2020
Lead Product(s) : OTO-6XX
Therapeutic Area : Otolaryngology (Ear, Nose, Throat)
Highest Development Status : Preclinical
Sponsor : Otonomy
Deal Size : Undisclosed
Deal Type : Licensing Agreement